Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein in complex with ACE2 (1-up state)
Resolution: 3.22 Å
EM Method: Single-particle
Fitted PDBs: 8xlm
Q-score: 0.382
Tsujino S, Deguchi S, Nomai T, Padilla-Blanco M, Plianchaisuk A, Wang L, Begum MM, Uriu K, Mizuma K, Nao N, Kojima I, Tsubo T, Li J, Matsumura Y, Nagao M, Oda Y, Tsuda M, Anraku Y, Kita S, Yajima H, Sasaki-Tabata K, Guo Z, Hinay Jr AA, Yoshimatsu K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Nasser H, Jonathan M, Putri O, Kim Y, Chen L, Suzuki R, Tamura T, Maenaka K, Irie T, Matsuno K, Tanaka S, Ito J, Ikeda T, Takayama K, Zahradnik J, Hashiguchi T, Fukuhara T, Sato K
Microbiol Immunol (2024) 68 pp. 305-330 [ Pubmed: 38961765 DOI: doi:10.1111/1348-0421.13165 ]
- 2-acetamido-2-deoxy-beta-d-glucopyranose (221 Da, Ligand)
- Spike glycoprotein (138 kDa, Protein from Severe acute respiratory syndrome coronavirus 2)
- Sars-cov-2 eg.5.1 spike glycoprotein (Complex from Severe acute respiratory syndrome coronavirus 2)
- Processed angiotensin-converting enzyme 2 (70 kDa, Protein from Homo sapiens)
- Sars-cov-2 eg.5.1 spike glycoprotein in complex with ace2 (90 kDa, Complex)
- Angiotensin-converting enzyme 2 (Complex from Homo sapiens)
Structure of the SARS-CoV-2 EG.5.1 spike RBD in complex with ACE2
Resolution: 3.78 Å
EM Method: Single-particle
Fitted PDBs: 8xln
Q-score: 0.447
Tsujino S, Deguchi S, Nomai T, Padilla-Blanco M, Plianchaisuk A, Wang L, Begum MM, Uriu K, Mizuma K, Nao N, Kojima I, Tsubo T, Li J, Matsumura Y, Nagao M, Oda Y, Tsuda M, Anraku Y, Kita S, Yajima H, Sasaki-Tabata K, Guo Z, Hinay Jr AA, Yoshimatsu K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Nasser H, Jonathan M, Putri O, Kim Y, Chen L, Suzuki R, Tamura T, Maenaka K, Irie T, Matsuno K, Tanaka S, Ito J, Ikeda T, Takayama K, Zahradnik J, Hashiguchi T, Fukuhara T, Sato K
Microbiol Immunol (2024) 68 pp. 305-330 [ Pubmed: 38961765 DOI: doi:10.1111/1348-0421.13165 ]
- 2-acetamido-2-deoxy-beta-d-glucopyranose (221 Da, Ligand)
- Spike glycoprotein (138 kDa, Protein from Severe acute respiratory syndrome coronavirus 2)
- Sars-cov-2 eg.5.1 spike glycoprotein (Complex from Severe acute respiratory syndrome coronavirus 2)
- Processed angiotensin-converting enzyme 2 (70 kDa, Protein from Homo sapiens)
- Sars-cov-2 eg.5.1 spike glycoprotein in complex with ace2 (90 kDa, Complex)
- Angiotensin-converting enzyme 2 (Complex from Homo sapiens)
SARS-CoV-2 EG.5.1 spike glycoprotein (1-up state)
Tsujino S, Deguchi S, Nomai T, Padilla-Blanco M, Plianchaisuk A, Wang L, Begum MM, Uriu K, Mizuma K, Nao N, Kojima I, Tsubo T, Li J, Matsumura Y, Nagao M, Oda Y, Tsuda M, Anraku Y, Kita S, Yajima H, Sasaki-Tabata K, Guo Z, Hinay Jr AA, Yoshimatsu K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Nasser H, Jonathan M, Putri O, Kim Y, Chen L, Suzuki R, Tamura T, Maenaka K, Irie T, Matsuno K, Tanaka S, Ito J, Ikeda T, Takayama K, Zahradnik J, Hashiguchi T, Fukuhara T, Sato K
Microbiol Immunol (2024) 68 pp. 305-330 [ Pubmed: 38961765 DOI: doi:10.1111/1348-0421.13165 ]
SARS-CoV-2 EG.5.1 spike glycoprotein (closed-2 state)
Resolution: 2.71 Å
EM Method: Single-particle
Fitted PDBs: 8wmd
Q-score: 0.484
Tsujino S, Deguchi S, Nomai T, Padilla-Blanco M, Plianchaisuk A, Wang L, Begum MM, Uriu K, Mizuma K, Nao N, Kojima I, Tsubo T, Li J, Matsumura Y, Nagao M, Oda Y, Tsuda M, Anraku Y, Kita S, Yajima H, Sasaki-Tabata K, Guo Z, Hinay Jr AA, Yoshimatsu K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Nasser H, Jonathan M, Putri O, Kim Y, Chen L, Suzuki R, Tamura T, Maenaka K, Irie T, Matsuno K, Tanaka S, Ito J, Ikeda T, Takayama K, Zahradnik J, Hashiguchi T, Fukuhara T, Sato K
Microbiol Immunol (2024) 68 pp. 305-330 [ Pubmed: 38961765 DOI: doi:10.1111/1348-0421.13165 ]
SARS-CoV-2 EG.5.1 spike glycoprotein (closed-1 state)
Resolution: 2.51 Å
EM Method: Single-particle
Fitted PDBs: 8wmf
Q-score: 0.571
Tsujino S, Deguchi S, Nomai T, Padilla-Blanco M, Plianchaisuk A, Wang L, Begum MM, Uriu K, Mizuma K, Nao N, Kojima I, Tsubo T, Li J, Matsumura Y, Nagao M, Oda Y, Tsuda M, Anraku Y, Kita S, Yajima H, Sasaki-Tabata K, Guo Z, Hinay Jr AA, Yoshimatsu K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Nasser H, Jonathan M, Putri O, Kim Y, Chen L, Suzuki R, Tamura T, Maenaka K, Irie T, Matsuno K, Tanaka S, Ito J, Ikeda T, Takayama K, Zahradnik J, Hashiguchi T, Fukuhara T, Sato K
Microbiol Immunol (2024) 68 pp. 305-330 [ Pubmed: 38961765 DOI: doi:10.1111/1348-0421.13165 ]
SARS-CoV-2 XBB.1 spike glycoprotein (closed-1 state)
Resolution: 2.5 Å
EM Method: Single-particle
Fitted PDBs: 8ios
Q-score: 0.579
Tamura T, Ito J, Uriu K, Zahradnik J, Kida I, Anraku Y, Nasser H, Shofa M, Oda Y, Lytras S, Nao N, Itakura Y, Deguchi S, Suzuki R, Wang L, Begum MM, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Shimizu R, Tsuda M, Kosugi Y, Fujita S, Pan L, Sauter D, Yoshimatsu K, Suzuki S, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Schreiber G, Maenaka K, Hashiguchi T, Ikeda T, Fukuhara T, Saito A, Tanaka S, Matsuno K, Takayama K, Sato K
Nat Commun (2023) 14 pp. 2800-2800 [ Pubmed: 37193706 DOI: doi:10.1038/s41467-023-38435-3 ]
SARS-CoV-2 XBB.1 spike glycoprotein (closed-2 state)
Resolution: 2.51 Å
EM Method: Single-particle
Fitted PDBs: 8iot
Q-score: 0.506
Tamura T, Ito J, Uriu K, Zahradnik J, Kida I, Anraku Y, Nasser H, Shofa M, Oda Y, Lytras S, Nao N, Itakura Y, Deguchi S, Suzuki R, Wang L, Begum MM, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Shimizu R, Tsuda M, Kosugi Y, Fujita S, Pan L, Sauter D, Yoshimatsu K, Suzuki S, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Schreiber G, Maenaka K, Hashiguchi T, Ikeda T, Fukuhara T, Saito A, Tanaka S, Matsuno K, Takayama K, Sato K
Nat Commun (2023) 14 pp. 2800-2800 [ Pubmed: 37193706 DOI: doi:10.1038/s41467-023-38435-3 ]
SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (1-up state)
Resolution: 3.18 Å
EM Method: Single-particle
Fitted PDBs: 8iou
Q-score: 0.388
Tamura T, Ito J, Uriu K, Zahradnik J, Kida I, Anraku Y, Nasser H, Shofa M, Oda Y, Lytras S, Nao N, Itakura Y, Deguchi S, Suzuki R, Wang L, Begum MM, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Shimizu R, Tsuda M, Kosugi Y, Fujita S, Pan L, Sauter D, Yoshimatsu K, Suzuki S, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Schreiber G, Maenaka K, Hashiguchi T, Ikeda T, Fukuhara T, Saito A, Tanaka S, Matsuno K, Takayama K, Sato K
Nat Commun (2023) 14 pp. 2800-2800 [ Pubmed: 37193706 DOI: doi:10.1038/s41467-023-38435-3 ]
- Spike glycoprotein (138 kDa, Protein from Severe acute respiratory syndrome coronavirus 2)
- Sars-cov-2 xbb.1 spike glycoprotein (420 kDa, Complex from Severe acute respiratory syndrome coronavirus 2)
- 2-acetamido-2-deoxy-beta-d-glucopyranose (221 Da, Ligand)
- Angiotensin-converting enzyme 2 (90 kDa, Complex from Homo sapiens)
- Processed angiotensin-converting enzyme 2 (70 kDa, Protein from Homo sapiens)
- Sars-cov-2 xbb.1 spike glycoprotein in complex with ace2 (510 kDa, Complex)
SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (2-up state)
Tamura T, Ito J, Uriu K, Zahradnik J, Kida I, Anraku Y, Nasser H, Shofa M, Oda Y, Lytras S, Nao N, Itakura Y, Deguchi S, Suzuki R, Wang L, Begum MM, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Shimizu R, Tsuda M, Kosugi Y, Fujita S, Pan L, Sauter D, Yoshimatsu K, Suzuki S, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Schreiber G, Maenaka K, Hashiguchi T, Ikeda T, Fukuhara T, Saito A, Tanaka S, Matsuno K, Takayama K, Sato K
Nat Commun (2023) 14 pp. 2800-2800 [ Pubmed: 37193706 DOI: doi:10.1038/s41467-023-38435-3 ]
- Sars-cov-2 xbb.1 spike glycoprotein (420 kDa, Complex from Severe acute respiratory syndrome coronavirus 2)
- Angiotensin-converting enzyme 2 (Protein from Homo sapiens)
- Sars-cov-2 xbb.1 spike glycoprotein (Protein from Severe acute respiratory syndrome coronavirus 2)
- Angiotensin-converting enzyme 2 (90 kDa, Complex from Homo sapiens)
- Sars-cov-2 xbb.1 spike glycoprotein in complex with ace2 (600 kDa, Complex)
SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 focused on RBD-ACE2 interface
Resolution: 3.29 Å
EM Method: Single-particle
Fitted PDBs: 8iov
Q-score: 0.459
Tamura T, Ito J, Uriu K, Zahradnik J, Kida I, Anraku Y, Nasser H, Shofa M, Oda Y, Lytras S, Nao N, Itakura Y, Deguchi S, Suzuki R, Wang L, Begum MM, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Shimizu R, Tsuda M, Kosugi Y, Fujita S, Pan L, Sauter D, Yoshimatsu K, Suzuki S, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Schreiber G, Maenaka K, Hashiguchi T, Ikeda T, Fukuhara T, Saito A, Tanaka S, Matsuno K, Takayama K, Sato K
Nat Commun (2023) 14 pp. 2800-2800 [ Pubmed: 37193706 DOI: doi:10.1038/s41467-023-38435-3 ]
- Spike glycoprotein (138 kDa, Protein from Severe acute respiratory syndrome coronavirus 2)
- Sars-cov-2 xbb.1 spike glycoprotein (420 kDa, Complex from Severe acute respiratory syndrome coronavirus 2)
- 2-acetamido-2-deoxy-beta-d-glucopyranose (221 Da, Ligand)
- Angiotensin-converting enzyme 2 (90 kDa, Complex from Homo sapiens)
- Processed angiotensin-converting enzyme 2 (70 kDa, Protein from Homo sapiens)
- Sars-cov-2 xbb spike glycoprotein in complex with ace2 (510 kDa, Complex)